Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CTAGE5 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA563130
Description
Immunogen sequence: TNDSLSLKPS WFDFGFAILG FAYAKEDKIM LDDRKNEEDG GADEHEHPLT SELDPEKEQE IETIKIIETE DQIDKKPVSE KTDESDTIP Highest antigen sequence identity to the following orthologs: Mouse - 52%, Rat - 47%.
CTAGE5/MIA-2 is a secreted cytokine, and a member of the MIA/OTOR family. Members of this family, which also includes MIA, OTOR, and TANGO, share a Src homology-3 (SH3)-like domain. MIA-2 is predominantly expressed in hepatocytes. Elevated levels of MIA-2 may represent a clinically useful marker for diagnosis of hepatic disease activity and severity.
Specifications
CTAGE5 | |
Polyclonal | |
Unconjugated | |
Mia2 | |
cTAGE family member 5; CTAGE family member 5 ER export factor; CTAGE family member 5, ER export factor; CTAGE family, member 5; CTAGE5; cutaneous T-cell lymphoma-associated antigen 5; LOW QUALITY PROTEIN: melanoma inhibitory activity protein 2; MEA11; MEA6; melanoma inhibitory activity 2; melanoma inhibitory activity protein 2; meningioma expressed antigen 6 (coiled-coil proline-rich); meningioma-expressed antigen 6/11; MGEA; MGEA11; MGEA6; MIA SH3 domain ER export factor 2; MIA2; protein cTAGE-5 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
4253 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunocytochemistry | |
0.3 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q96PC5 | |
Mia2 | |
Recombinant protein corresponding to Human MIA2. Recombinant protein control fragment (Product #RP-101373). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction